Kevin M. Brennan - SVP, FINANCE AND ACCOUNTING at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Finance And Accounting
Stock Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin M. Brennan since 9/17/2023

Holdings reported by Kevin M. Brennan for Xilio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 20K $205K $10.24 Jan 1, 2024 Direct Common Stock
Stock Option (right to buy) 20K May 1, 2024 Direct Common Stock

Transactions reported by Kevin M. Brennan for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.